Ito Takao, Igaki Tatsushi
Laboratory of Genetics, Graduate School of Biostudies, Kyoto University, Yoshida-Konoecho-cho, Sakyo-ku, Kyoto, 606-8501, Japan.
Inflamm Regen. 2016 Dec 5;36:25. doi: 10.1186/s41232-016-0031-4. eCollection 2016.
Cellular senescence can act as both tumor suppressor and tumor promoter depending on the cellular contexts. On one hand, premature senescence has been considered as an innate host defense mechanism against carcinogenesis in mammals. In response to various stresses including oxidative stress, DNA damage, and oncogenic stress, suffered cells undergo irreversible cell cycle arrest, leading to tumor suppression. On the other hand, recent studies in mammalian systems have revealed that senescent cells can drive oncogenesis by secreting diverse proteins such as inflammatory cytokines, matrix remodeling factors, and growth factors, the phenomenon called senescence-associated secretory phenotype (SASP). However, the mechanisms by which these contradictory effects regulate tumor growth and metastasis in vivo have been elusive. Here, we review the recent discovery of cellular senescence in and the mechanisms underlying senescence-mediated tumor regulation dissected by genetics.
细胞衰老根据细胞环境的不同,既可以起到肿瘤抑制作用,也可以起到肿瘤促进作用。一方面,过早衰老被认为是哺乳动物对抗肿瘤发生的一种固有宿主防御机制。在应对包括氧化应激、DNA损伤和致癌应激等各种应激时,遭受应激的细胞会经历不可逆的细胞周期停滞,从而导致肿瘤抑制。另一方面,最近在哺乳动物系统中的研究表明,衰老细胞可以通过分泌多种蛋白质(如炎性细胞因子、基质重塑因子和生长因子)来驱动肿瘤发生,这种现象被称为衰老相关分泌表型(SASP)。然而,这些相互矛盾的效应在体内调节肿瘤生长和转移的机制一直难以捉摸。在这里,我们综述了细胞衰老的最新发现,以及通过遗传学剖析的衰老介导的肿瘤调节的潜在机制。